Drugs from the Sea: A Marine Sponge-Derived Compound Prevents Type 1 Diabetes
Author(s) -
Luc Van Kaer
Publication year - 2001
Publication title -
the scientific world journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.453
H-Index - 93
eISSN - 2356-6140
pISSN - 1537-744X
DOI - 10.1100/tsw.2001.357
Subject(s) - diabetes mellitus , type 2 diabetes , medicine , insulin , pancreas , blood sugar , disease , stroke (engine) , blindness , type 1 diabetes , endocrinology , intensive care medicine , pediatrics , mechanical engineering , optometry , engineering
More than one million Americans have Type 1 diabetes. This disease--also known as autoimmune or juvenile diabetes--strikes children suddenly, makes them dependent on insulin injections for life, and carries the constant threat of devastating complications. While it can and does strike adults, nearly half of all new cases are diagnosed in children. A child is diagnosed with Type 1 diabetes every hour. Type 1 diabetes is caused by the inability of a person"s pancreas to produce sufficient amounts of insulin to control their blood sugar levels and sustain life. While insulin injections allow affected individuals to control their blood sugar and stay alive, it is not a cure nor does it prevent the devastating complications of this disease, which include kidney failure, blindness, amputations, heart attack, and stroke. In Type 1 diabetes, the body"s own immune system goes awry, attacking and destroying insulin-producing cells in the pancreas.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom